CVS Health Corp.
CVS | NYSE
$90.24
-$0.09 (-0.10%)
At close: Oct 30, 2026, 3:59 PM ET
$90.33
+$0.09 (+0.10%)
Pre-market:
Nov 2, 2026, 4:41 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 402.07B | 372.81B | 357.78B | 322.47B | 292.11B | 268.71B |
Cost of Revenue | 346.71B | 321.41B | 303.35B | 267.97B | 239.99B | 219.66B |
Gross Profit | 55.36B | 51.4B | 54.43B | 54.5B | 52.12B | 49.05B |
Operating Income | 10.39B | 8.52B | 13.74B | 7.95B | 13.31B | 13.91B |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 2.14B | 6.15B | 11.17B | 5.84B | 10.54B | 9.77B |
Net Income | 1.77B | 4.61B | 8.34B | 4.31B | 8B | 7.18B |
Selling & General & Admin | n/a | 41.23B | n/a | n/a | n/a | n/a |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 44.98B | 1.66B | 40.69B | 46.55B | 38.81B | 35.14B |
Operating Expenses | 44.98B | 42.89B | 40.69B | 46.55B | 38.81B | 35.14B |
Interest Expense | 3.12B | 2.96B | 2.66B | 2.29B | 2.5B | 2.91B |
Selling & Marketing Expenses | n/a | 989M | n/a | n/a | n/a | n/a |
Cost & Expenses | 391.68B | 364.29B | 344.03B | 314.51B | 278.8B | 254.8B |
Income Tax Expense | 408M | 1.56B | 2.81B | 1.51B | 2.55B | 2.57B |
Shares Outstanding (Basic) | 1.27B | 1.26B | 1.29B | 1.31B | 1.32B | 1.31B |
Shares Outstanding (Diluted) | 1.27B | 1.26B | 1.29B | 1.32B | 1.33B | 1.31B |
EPS (Basic) | 1.40 | 3.66 | 6.49 | 3.29 | 6 | 5.48 |
EPS (Diluted) | 1.39 | 3.66 | 6.47 | 3.26 | 5.95 | 5.46 |
EBITDA | 9.86B | 13.68B | 18.2B | 12.35B | 17.53B | 17.12B |
EBIT | 5.26B | 9.11B | 13.83B | 8.12B | 13.04B | 12.68B |
Depreciation & Amortization | 4.61B | 4.6B | 4.37B | 4.22B | 4.49B | 4.44B |
Add to Watchlist
Select watchlists to add or remove CVS